A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Tenecteplase (Primary)
- Indications Catheter thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms TROPICS-3
- Sponsors Genentech
- 02 Jun 2010 Actual patient number changed from 151 to 150 as reported by ClinicalTrials.gov.
- 24 Dec 2009 New trial record.